Skip to main content

Table 3 Comparison between active-acupuncture and placebo-acupuncture groups in occurrence rate and severity of nausea

From: Effect of transcutaneous electrical acupoint stimulation combined with palonosetron on chemotherapy-induced nausea and vomiting: a single-blind, randomized, controlled trial

Time after TACE (days) Patients with nausea [cases (%)] P Severity of nausea [cases (%)] P
Placebo-acupuncture group Active-acupuncture group
Placebo-acupuncture group Acupu-ncture group Degree 1 Degree 2 Degree 3 Degree 1 Degree 2 Degree 3
0 34 (48.6) 26 (36.1) 0.133 36 (51.4) 22 (31.4) 12 (17.1) 46 (63.9) 19 (26.4) 7 (9.7) 0.256
1 30 (42.9) 26 (36.1) 0.411 40 (57.1) 20 (28.6) 10 (14.3) 46 (63.9) 15 (20.8) 11 (15.3) 0.562
2 30 (42.9) 28 (38.9) 0.631 40 (57.1) 18 (25.7) 12 (17.1) 44 (61.1) 21 (29.2) 7 (9.7) 0.426
3 21 (30.0) 22 (30.1) 0.943 49 (70.0) 15 (21.4) 6 (8.6) 50 (69.4) 16 (22.2) 6 (8.3) 0.993
4 19 (27.1) 17 (23.6) 0.629 51 (72.9) 16 (22.9) 3 (4.3) 55 (76.4) 13 (18.1) 4 (5.6) 0.750
5 14 (20.0) 13 (18.0) 0.768 56 (80.0) 12 (17.1) 2 (2.9) 59 (81.9) 9 (12.5) 4 (5.6) 0.564
  1. Degree1: No nausea; degree 2: very mild to moderate nausea; degree 3: severe to intolerable nausea
  2. TACE transcatheter arterial chemoembolization